DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Mukka Proteins Limited — Acquisition

NSE 40 min ago·30 Sept 2026, 7:04 am

Mukka Proteins

Mukka Proteins Limited has announced an update regarding a pending acquisition. The company has informed the stock exchange about the progress of this strategic deal, which is a key development for its future growth plans.

This news matters to investors as it signals Mukka Proteins' intent to expand its operations. Such corporate actions can potentially enhance the company's market presence and long-term value, though the exact impact depends on the deal's terms.

Investors should watch for further details on the target company and the financial implications of the transaction. Keeping an eye on regulatory approvals and the final agreement will be crucial for understanding the full scope of this development.